CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Erytech Pharma SA - ADR Company Snapshot
Erytech Pharma SA operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other companies in this sector in the United States: Fate Therapeutics Inc (2018 sales of $4.74 million of which 100% was Biopharmaceuticals), Organovo Holdings Incorporated ($4.60 million of which 100% was Developing and Commercializing Human Tis), and Lineage Cell Therapeutics Inc ($4.99 million of which 100% was Synthetic Solutions).

Sales Analysis. During the year ended December of 2018, sales at Erytech Pharma SA were $5.24 million. This is an increase of 36.7% versus 2017, when the company's sales were $3.83 million.
   
   
 
  Stock Performance Chart for Erytech Pharma SA - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (11/26/2019): 4.91
(Figures in U.S. Dollars)
1 Week 0.1%   13 Weeks 13.7%  
4 Weeks n/a   52 Weeks -36.7%  
 
Erytech Pharma SA - ADR Key Data:
  Ticker: ERYP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 5,239,722
(Year Ending Jan 2019).
Employees: 172
  Currency: U.S. Dollars Market Cap: 88,073,297
  Fiscal Yr Ends: December Shares Outstanding: 17,937,535
  Share Type: Common Closely Held Shares: 451,794
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.